Project Grant HT94252310545
Award Date 7/1/23
Completion Date 6/30/26
Dollars Obligated $366K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
- The Johns Hopkins University received a $722,589.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on localized and inflammation-responsive immunotherapy of vascular composite allograft (VCA) rejection. The 3-year project, which commenced on July 1, 2023 and is slated for completion by June 30, 2026, aims to transform healthcare for service members and the American public by investigating innovative...
- This $499,957 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by The Johns Hopkins University to investigate extracellular vesicle-mediated PD-L1 upregulation in vascularized composite allotransplantation (VCA) grafts for immune tolerance. The research aims to advance understanding of mechanisms for improving immune tolerance in VCA transplants, which have potential applications for improving...
- The Johns Hopkins University was awarded a $974,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, spanning August 1, 2023 to July 31, 2026, will support research to engineer an effective combination therapy of car T cells and regulatory T cells to control rejection of vascularized composite allografts. This research aims to develop medical solutions for the battlefield and transform healthcare for...
- Federal Grant Award Summary The Johns Hopkins University received a $606,060 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 15, 2025 through July 14, 2027. The project, titled "Engineering Receptors to Promote Effective Infiltration of CAR T Cells into Bladder Tumors," supports advanced biomedical research aimed at developing innovative cancer immunotherapy approaches relevant to...
- This $867,712 Project Grant award from the Department of the Army Medical Command (under the Military Medical Research and Development program, CFDA 12.420) supports advanced biomedical research at The Johns Hopkins University focused on transforming healthcare for military service members and the general public. The research aims to investigate effective treatment of pancreatic cancer through systemic chemotherapy combined with alpha-particle radiotherapy, with a focus on early hepatic...
- The Johns Hopkins University will provide research services under a $724,845 Project Grant from the Defense Health Agency's Military Medical Research and Development program. Specifically, Johns Hopkins will conduct applied biomedical studies from June 2023 through May 2026 to regenerate chronically denervated muscle through development of an injectable myoblast scaffold. The Military Medical Research and Development program aims to transform military and public health through innovative...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Johns Hopkins University a Project Grant totaling $776,831 under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025 through July 31, 2028. The award supports research on P2 purinergic receptors in pancreatic ductal adenocarcinoma as therapeutic targets, conducted at the institution's Baltimore, Maryland facility. This three-year research initiative represents DHA's investment...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,738,924 Project Grant to The Johns Hopkins University to conduct research on "Proteomics of Atrioventricular Septal Defect in Down Syndrome" from September 1, 2024 through August 31, 2028. This research, funded under the Military Medical Research and Development program (CFDA 12.420), aims to advance scientific understanding and treatment of this condition impacting military members, veterans, and their families. The...
- This $1,473,430 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research on pluripotent stem cell-derived corneal endothelial cells for the treatment of combat laser-induced corneal edema and vision restoration. Spanning from September 1, 2024 to August 31, 2027, this award will enable Johns Hopkins to conduct innovative biomedical research to develop new treatments for military...
- The Johns Hopkins University was awarded a $1,228,125 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research titled "PSMA-TARGETED ACTIVATED MYELOID CELLS AS A NOVEL PROSTATE CANCER IMMUNOTHERAPY" from September 2021 through September 2024. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...